Nuveen Asset Management, LLC Ironwood Pharmaceuticals Inc Transaction History
Nuveen Asset Management, LLC
- $340 Billion
- Q4 2024
A detailed history of Nuveen Asset Management, LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 405,354 shares of IRWD stock, worth $640,459. This represents 0.0% of its overall portfolio holdings.
Number of Shares
405,354
Previous 405,354
-0.0%
Holding current value
$640,459
Previous $1.67 Million
7.74%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding IRWD
# of Institutions
177Shares Held
160MCall Options Held
11.2MPut Options Held
0-
Black Rock Inc. New York, NY22.9MShares$36.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.2MShares$25.6 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY16.2MShares$25.5 Million0.2% of portfolio
-
Sarissa Capital Management LP Greenwich, CT15.9MShares$25.2 Million8.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny8.41MShares$13.3 Million0.01% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $242M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...